Improved molecular switch could serve as sensor, medical tool
Device made of fused protein partners is shown to be reversible and highly sensitive
Improving significantly on an early prototype, Johns Hopkins University researchers have found a new way to join two unrelated proteins to create a molecular switch, a nanoscale "device" in which one biochemical partner controls the activity of the other. Lab experiments have demonstrated that the new switch performs 10 times more effectively than the early model and that its "on-off" effect is repeatable.
The new technique to produce the molecular switch and related experimental results are reported in the November issue of the journal Chemistry & Biology. The paper builds on earlier research, led by Marc Ostermeier, which demonstrated that it was possible to create a fused protein in which one component sends instructions to the other. The second then carries out the task. "Last year, we reported that wed used protein engineering techniques to make a molecular switch, putting together two proteins that normally had nothing to do with one another, but the switching properties of that version were insufficient for many applications," said Ostermeier, an assistant professor in the Department of Chemical and Biomolecular Engineering at Johns Hopkins. "With the new technique, weve produced a molecular switch thats over 10 times more effective. When we introduce this switch into bacteria, it transforms them into a working sensor."
As in their earlier experiments, Ostermeiers team made a molecular switch by joining two proteins that typically do not interact: beta-lactamase and the maltose binding protein found in a harmless form of E. coli bacteria. Each of these proteins has a distinct activity that makes it easy to monitor. Beta-lactamase is an enzyme that can disable and degrade penicillin-like antibiotics. Maltose binding protein binds to a type of sugar called maltose that E. coli cells can use as food.
In the previous experiments, the researchers used a cut-and-paste process to insert the beta-lactamase protein into a variety of locations on the maltose binding protein, both proteins being long chains of amino acids that can be thought of as long ribbons. In the new process, the team joined the two natural ends of the beta-lactamase chain to create one continuous molecular loop. Then, they snipped this "ribbon" at random points before inserting the beta-lactamase in random locations in the maltose binding protein. This technique, called random circular permutation, increases the likelihood that the two proteins will be fused in a manner in which they can communicate with each other, Ostermeier said. As a result, its more likely that a strong signal will be transmitted from one partner to the other in some of the combined proteins.
In their new paper, the Johns Hopkins team reported that this technique yielded approximately 27,000 variations of the fused proteins. Among these, they isolated one molecular switch, in which the presence of maltose, detected by one partner, caused the other partner to increase its attack on an antibiotic 25-fold. They also showed that the switch could be turned off: When the maltose triggering agent was removed, the degradation of the antibiotic instantly slowed to its original pace.
Ostermeier believes the same molecular switch technology could be used to produce "smart" materials, medical devices that can detect cancer cells and release drugs, and sensors that could sound an alarm in the presence of chemical or biological agents. His team is now seeking to create a molecular switch that fluorescently lights up only in the presence of certain cellular activity. "Weve proven that we can make effective molecular switches," he said. "Now, we want to use this idea to create more interesting and more useful devices."
Gurkan Guntas, a doctoral student in Ostermeiers lab, was lead author on the new Chemistry & Biology paper. The co-authors were Ostermeier and Sarah F. Mitchell, a doctoral student in the Program in Molecular Biophysics at Johns Hopkins. The research was supported by a grant from the National Institutes of Health. The Johns Hopkins University has applied for a patent covering the molecular switch and methods of producing it.
Phil Sneiderman | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Mapping the interaction of a single atom with a single photon may inform design of quantum devices
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...